Viewing Study NCT00023335


Ignite Creation Date: 2025-12-24 @ 10:31 PM
Ignite Modification Date: 2025-12-25 @ 8:04 PM
Study NCT ID: NCT00023335
Status: COMPLETED
Last Update Posted: 2005-09-05
First Post: 2001-09-06
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: TBTC Study 22: Efficacy of Once-Weekly Rifapentine and Isoniazid in Treatment of Tuberculosis
Sponsor: Centers for Disease Control and Prevention
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module References Module